HomeInsightsPE

Shukra Pharmaceuticals Ltd PE Ratio

Shukra Pharmaceuticals Ltd PE Ratio

stocks purchased

₹ 0.1 Cr

Volume transacted

stocks purchased

12.7 K

stocks traded

Last Updated time: 19 Sep 15:30 PM

Image

Shukra Pharmaceuticals Ltd

NSE: SHUKRAPHARMA

PE

14.8

Last updated: 19 Sep 15:30 PM

Key Highlights

  • The P/E Ratio of Shukra Pharmaceuticals Ltd is 14.8 as of 19 Sep 15:30 PM.
  • The P/E Ratio of Shukra Pharmaceuticals Ltd changed from 12.4 on March 2019 to 19.3 on March 2024 . This represents a CAGR of 7.65% over 6 years. .
  • The Latest Trading Price of Shukra Pharmaceuticals Ltd is ₹ 62.71 as of 19 Sep 15:30.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 21.8. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.2. The PE Ratio of Retail industry is 164.1. The PE Ratio of Textiles industry is 35.8. In 2024.

Historical P/E Ratio of Shukra Pharmaceuticals Ltd

No data available

Company Fundamentals for Shukra Pharmaceuticals Ltd

No data available

Image

Shukra Pharmaceuticals Ltd

NSE: SHUKRAPHARMA

PRICE

62.71

-0.31 (-0.49%)

stock direction

Last updated: 19 Sep 15:30

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Shukra Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
19 Sep 202462.71
18 Sep 202463.02
17 Sep 202463.66
16 Sep 202463.69
13 Sep 202463.87
12 Sep 202462.37
11 Sep 202464.09
10 Sep 202464.52
09 Sep 202462.51
06 Sep 202461.85

SWOT Analysis Of Shukra Pharmaceuticals Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Shukra Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Shukra Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Shukra Pharmaceuticals Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Shukra Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Shukra Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Shukra Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Shukra Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payout of Shukra Pharmaceuticals Ltd

No data available

* All values are in %

About Shukra Pharmaceuticals Ltd

  • Shukra Pharmaceuticals Ltd (Formerly known Relish Pharmaceuticals Limited) was established in March 1993 and later on the name of Company got changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on 22 September, 2016.
  • The Company is presently engaged in the business of manufacturing of pharmaceuticals Products and laboratory testing.
  • The company provides varieties of products to the clientele.
  • Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others.

Shukra Pharmaceuticals Ltd News Hub

News

Shukra Pharmaceuticals to hold AGM

Shukra Pharmaceuticals announced that the 31th Annual General Meeting (AGM) of the company...

Read more

16 Sep 202410:13

News

Shukra Pharmaceuticals to discuss results

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 ...

Read more

05 Aug 202410:57

News

Shukra Pharmaceuticals schedules EGM

Shukra Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Compa...

Read more

31 Jul 202417:47

News

Board of Shukra Pharmaceuticals recommends final dividend

Shukra Pharmaceuticals announced that the Board of Directors of the Company at its meeting...

Read more

30 May 202412:16

News

Shukra Pharmaceuticals to announce Quarterly Result

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 ...

Read more

21 May 202413:01

News

Board of Shukra Pharmaceuticals allots 3.28 cr bonus shares

The Board of Shukra Pharmaceuticals at its meeting held on 25 April 2024 has allotted 3,28...

Read more

25 Apr 202420:01

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Shukra Pharmaceuticals Ltd

What is the current PE Ratio of Shukra Pharmaceuticals Ltd?

The Current PE Ratio of Shukra Pharmaceuticals Ltd is 14.76 as on 19 Sep 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.2 as on 19 Sep 2024.

What was the PE Ratio of Shukra Pharmaceuticals Ltd last year?

The PE Ratio of Shukra Pharmaceuticals Ltd was 4.17 last year, now the PE ratio is 14.76, showing a year-on-year growth of 254.0%.

What does the PE Ratio of Shukra Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Shukra Pharmaceuticals Ltd is 14.76. This ratio indicates that investors are willing to pay 14.76 times the earnings per share for each share of Shukra Pharmaceuticals Ltd.

What is the PE Ratio Growth of Shukra Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Shukra Pharmaceuticals Ltd grew by 254.0% whereas, the EPS ratio grew by -97.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*